New: our own Hairmetry line. Every ingredient explained

Topic

When to see a dermatologist

Most gradual thinning is pattern loss you can start treating yourself, but scarring signs, scalp symptoms, patches or sudden shedding should go to a clinician quickly because delay can cost permanent hair.

hair lossthinningsheddingitchy scalpdandruffbreakage

Most gradual hair thinning is pattern loss and can be started on over-the-counter treatment (see the treatment ladder). Some presentations should skip the shelf and go to a clinician quickly, because delay can cost permanent hair or miss a medical problem. This page lists those red flags with the evidence behind each. It is a triage aid, not a diagnosis.

Key takeaways

  • Scarring (cicatricial) alopecias destroy follicles permanently, so earlier treatment preserves more hair. The European task force stresses early diagnosis in lichen planopilaris (Seyed Jafari 2026).
  • Symptoms on the scalp are the biggest red flag: pain, burning, tenderness, stinging, itching with scale or crust, tiny bumps, or a smooth shiny patch (Seyed Jafari 2026).
  • A hairline that recedes with thinned eyebrows, or beard loss in men, is not normal ageing: think frontal fibrosing alopecia (Melian-Olivera 2025).
  • In curly or coily hair, centre-crown breakage can be the first sign of CCCA, and diagnosis is often late (Issa 2026). Misdiagnosis of scalp conditions in skin of colour is documented (McMullen 2026); ask directly about a biopsy if first-line treatment fails.
  • Scaly bald patches in a child are tinea capitis until proven otherwise. They need an oral antifungal and a lab test, and shampoo will not cure them (Mayser 2026).
  • Hair loss can be the visible edge of a systemic problem such as thyroid disease, iron deficiency, androgen excess like PCOS, or a medicine. In women with pattern loss, an expert report recommends assessing for androgen excess and suggests checking vitamin D, iron, zinc, thyroid hormones and prolactin (Carmina 2019).
  • Compulsive hair pulling responds to behavioural therapy and benefits from specialist input (Fisak 2026).

Red flag checklist

Red flag Possible meaning How fast
Scalp pain, burning, tenderness, stinging Scarring alopecia (lichen planopilaris, frontal fibrosing, CCCA), infection, inflammatory disease Within weeks
Smooth, shiny bald patch with no visible follicle openings Scarring, permanent Soon
Redness, scale around hair shafts, tiny bumps or pustules, crusts Lichen planopilaris, folliculitis, tinea, psoriasis Soon
Receding hairline plus eyebrow or eyelash thinning, facial bumps Frontal fibrosing alopecia Soon
Crown breakage or thinning spreading in a circle, especially in 3B to 4C hair CCCA Soon
Tight-style hairline loss that does not recover once loosened Scarring traction alopecia or frontal fibrosing alopecia Within 1 to 3 months
Round, well-defined patches; eyebrow, lash or beard patches Alopecia areata; a severe form has an approved drug (baricitinib) Within weeks
Sudden heavy shedding or thinning over weeks Telogen effluvium or an acute trigger Within weeks, with bloods
Scaly patch with broken hairs, black dots, swelling or enlarged neck nodes, especially in a child Tinea capitis Days
Patches with irregular broken hairs and visible distress Trichotillomania Routine, but support helps
Hair loss in a child, or brittle sparse hair since infancy Hair shaft disorder or a syndrome, tight styles, tinea Soon
Hair loss with fatigue, weight change, temperature intolerance, irregular periods, acne, facial hair, rash or joint pain Thyroid, PCOS, lupus, anaemia (see PCOS and hair, thyroid and hair) Soon
Hair loss after starting a new medicine or changing hormones or contraceptive Drug effect Ask your prescriber before stopping
Pregnant, postpartum or planning pregnancy while on hair treatments Medication safety Before any prescription step (Brinks 2026)
Treatment side effects: chest pain, fainting, swelling, mood or sexual changes Adverse drug effects Urgent, contact the prescriber
No improvement after 6 to 12 months of a proven treatment Wrong diagnosis or dose Routine review

What a dermatologist does

They examine the hairline, scalp and eyebrows, ask about symptoms and medicines, may use a dermatoscope (Pirmez 2023), and often take a small scalp biopsy under local anaesthetic to confirm the type. Pull tests and blood tests complete the work-up. Biopsy and prescribing need a doctor.

In lymphocytic scarring alopecias such as lichen planopilaris and frontal fibrosing alopecia, immune cells attack the follicle and the loss is irreversible, so the treatment aim is stabilization. Dutasteride, steroids and hydroxychloroquine are used off-label for frontal fibrosing alopecia, and randomized evidence is very limited (Saceda-Corralo 2026).

Delays are common. Older adults with tinea capitis were misdiagnosed in 37.4% of reported cases (Valdez-Martinez 2025).

Hair type notes

  • Curl 3A to 4C and protective styles: check the crown and edges with a mirror monthly, because styles can hide both traction and CCCA. Ask for a clinician experienced in textured hair, and for a biopsy if the first diagnosis of dryness or dandruff does not respond.
  • Straight or fine hair: thinning shows earlier at the part, and pattern loss is likelier.
  • Oily or flaky scalp: persistent flaking with hair loss that does not improve after a few weeks of medicated shampoo is a reason to check for tinea or inflammatory disease (see sebum and scalp types).
  • Children: see within days for scaly patches, and prevent tight braids on young girls (see traction and hairstyles).
  • Men with an early receding hairline can start proven treatments, but a hairline with brow loss still needs a check. Women with irregular periods or excess facial hair need a hormone assessment.

Myths and facts

  • "Wait six months and see" is fine for mild gradual shedding, not for scarring signs.
  • A trichologist cannot biopsy or prescribe; that needs a doctor.
  • If it does not hurt it is not necessarily harmless: many scarring alopecias are silent.
  • Photographs help. Bring dated photos, a medication list and family history.

Bottom line

Take photos now of the hairline, part, crown and brows in the same light, and repeat monthly. Write down onset, symptoms, new products, styles, illnesses, medicines, family history and periods. Book a board-certified dermatologist, or in the UK your GP and then a dermatology referral; private teledermatology can triage but cannot biopsy. Request bloods only when guided by history, and do not self-supplement iron without a result (see iron and ferritin). Do not start new potent products on an inflamed or painful scalp before diagnosis. Once pattern loss is confirmed, see the treatment ladder. Discuss with a doctor.

Studies 11

Seyed Jafari SM et al. Management of classic lichen planopilaris: EADV task force position statement. J Eur Acad Dermatol Venereol. 2026

Design
guideline
Who
expert task force

Tested: management of lichen planopilaris

Result: First-line potent topical and injected steroids, systemic or combination therapy for severe or resistant disease; no head-to-head trials; early treatment matters.

Read the study ↗

Melian-Olivera A et al. Frontal fibrosing alopecia in men: a review of the literature. J Clin Med. 2025

Design
review
Who
men with frontal fibrosing alopecia

Tested: review

Result: Often misdiagnosed as pattern hair loss or alopecia areata; eyebrow loss in 43-94.9% of reviewed series and early beard and sideburn involvement are clues.

Read the study ↗

Issa T et al. Central centrifugal cicatricial alopecia associated with longer time to diagnosis among scarring alopecias. JAAD Int. 2025

Design
other
Who
patients with scarring alopecias

Tested: time-to-diagnosis analysis

Result: CCCA had a longer time to diagnosis than other scarring alopecias.

Read the study ↗

McMullen E et al. Misdiagnoses of hair and scalp disorders in adults with skin of color. Int J Dermatol. 2026

Design
other
Who
adults with skin of colour and hair or scalp disorders

Tested: review of misdiagnosis

Result: Misdiagnosis of hair and scalp disorders in adults with skin of colour is documented.

Read the study ↗

Mayser P et al. Consensus-based guideline on tinea capitis. J Dtsch Dermatol Ges. 2026

Design
guideline
Who
people with tinea capitis

Tested: guideline recommendations

Result: Terbinafine first-line for adults; in children terbinafine (off-label) for Trichophyton and itraconazole (off-label) or griseofulvin for Microsporum; covers carriers and outbreaks.

Read the study ↗

Valdez-Martinez A et al. Tinea capitis in older adults: systematic review of reported cases. Antibiotics. 2025

Design
systematic review
People
91
Who
older adults with tinea capitis

Tested: review of reported cases

Result: 37.4% were misdiagnosed and 40.7% had used topical steroids.

Read the study ↗
Show 5 more studies

Carmina E et al. Female pattern hair loss and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019

Design
guideline
Who
women with female pattern hair loss

Tested: expert report

Result: Every woman with female pattern loss should be assessed for androgen excess; isolated loss with normal androgens is not a sign of hyperandrogenism; start treatment with minoxidil 5%.

Read the study ↗

Fisak B et al. Efficacy of psychotherapeutic and pharmacological interventions for trichotillomania: review and meta-analysis. J Psychiatr Res. 2026

Design
meta analysis
Who
people with trichotillomania (29 RCTs)

Tested: psychotherapies and medicines

Result: Strong support for habit reversal training, ACT-enhanced habit reversal and N-acetylcysteine; clonazepam not consistently supported.

Read the study ↗

Saceda-Corralo D et al. Consensus document on the clinical management of frontal fibrosing alopecia (AEDV). Actas Dermosifiliogr. 2026

Design
guideline
Who
Spanish expert panel

Tested: management consensus

Result: Recommends combining oral dutasteride with topical or injected agents, adding hydroxychloroquine if inflammation persists.

Read the study ↗

Brinks AL et al. Safety of alopecia therapies during pregnancy, fertility treatment and PCOS workup. Int J Womens Dermatol. 2026

Design
review
Who
women who are pregnant, planning pregnancy, or being worked up for PCOS

Tested: alopecia therapies

Result: Anti-androgens and 5-alpha-reductase inhibitors are unsuitable in pregnancy; some therapies can alter hormone labs or mask PCOS signs.

Read the study ↗

Pirmez R. The dermatoscope in the hair clinic. J Am Acad Dermatol. 2023

Design
review
Who
patients in hair clinics

Tested: dermatoscopy (trichoscopy)

Result: The dermatoscope is a core tool for examining hair and scalp disease.

Read the study ↗